DOCETAXEL-PREDNISONE (DP) PLUS METRONOMIC CYCLOPHOSPHAMIDE (CTX) AND CELECOXIB (C) AS FIRST LINE TREATMENT IN CASTRATION RESISTANT PROSTATE CANCER (CRPC): PHASE II TRIAL WITH PHARMACODYNAMIC EVALUATION
ANNALS OF ONCOLOGY（2009）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined